These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 2446363

  • 1. [Inhibition of pancreatic apudoma-dependent hypersecretion of gastrin, glucagon and serotonin using somatostatin-14].
    Varas Lorenzo MV.
    Rev Esp Enferm Apar Dig; 1987 Oct; 72(4 Pt 1):329-33. PubMed ID: 2446363
    [No Abstract] [Full Text] [Related]

  • 2. Metastatic pancreatic islet cell carcinoma causing manifestations of glucagon and gastrin hypersecretion.
    Ferrara JJ, Fucci JC, Benson JB.
    Conn Med; 1985 Dec; 49(12):777-80. PubMed ID: 3002718
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Necrolytic migratory erythema associated with alteration from predominantly gastrin-secreting to predominantly glucagon-secreting pancreatic neuroendocrine tumor.
    Kido-Nakahara M, Nakahara T, Miki M, Igarashi H, Ito T, Furue M.
    Eur J Dermatol; 2014 Dec; 24(6):702-3. PubMed ID: 25333507
    [No Abstract] [Full Text] [Related]

  • 6. Observations on the effect of a somatostatin analog in the Zollinger-Ellison syndrome: implications for the treatment of apudomas.
    Ellison EC, O'Dorisio TM, Sparks J, Mekhjian HS, Fromkes JJ, Woltering EA, Carey LC.
    Surgery; 1986 Aug; 100(2):437-44. PubMed ID: 2426819
    [Abstract] [Full Text] [Related]

  • 7. [Peptide-producing tumors in the pancreas and gastrointestinal tract: syndrome, survey, therapy].
    Hemmingson A, Johansson H, Lindgren PG, Lundqvist G, Lörelius LE, Wide L, Wilander E, Oberg K.
    Lakartidningen; 1984 Aug 29; 81(35):3015-21. PubMed ID: 6147450
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Symptomatic secondary hormone syndromes in patients with established malignant pancreatic endocrine tumors.
    Wynick D, Williams SJ, Bloom SR.
    N Engl J Med; 1988 Sep 08; 319(10):605-7. PubMed ID: 2842676
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Hormone immunocytochemical studies of 46 endocrine tumors of the pancreas in 24 patients].
    Le Bodic MF, Cloarec D, Lehur PA, Visset J, Le Bodic L.
    Gastroenterol Clin Biol; 1986 Apr 08; 10(4):334-40. PubMed ID: 3013709
    [Abstract] [Full Text] [Related]

  • 12. [Gastrin-secreting tumors].
    Wasylewski A, Krzyszkowska A.
    Pol Tyg Lek; 1978 Jun 12; 33(24):973-5. PubMed ID: 29287
    [No Abstract] [Full Text] [Related]

  • 13. Clinical and hormonal effects of a long-acting somatostatin analogue in pancreatic endocrine tumors and in carcinoid syndrome.
    Souquet JC, Sassolas G, Forichon J, Champetier P, Partensky C, Chayvialle JA.
    Cancer; 1987 May 01; 59(9):1654-60. PubMed ID: 2435403
    [Abstract] [Full Text] [Related]

  • 14. Clinical aspects of gastrointestinal hormones.
    Lamers CB.
    Neth J Med; 1978 May 01; 21(2):77-82. PubMed ID: 206847
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pathology of peptide-producing neuroendocrine tumours.
    Polak JM, Bloom SR.
    Br J Hosp Med; 1985 Feb 01; 33(2):78, 80-2, 87-8. PubMed ID: 2982443
    [Abstract] [Full Text] [Related]

  • 17. Effect of somatostatin analogue (SMS 201-995) on molecular species of gastrin in gastrinoma.
    Campagnolo D, Gower WR, Fabri PJ, Sparks J, Mekhjian HS, O'Dorisio TM, Ellison EC.
    Surgery; 1987 Dec 01; 102(6):982-7. PubMed ID: 2891204
    [Abstract] [Full Text] [Related]

  • 18. Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumors.
    Woltering EA, Mozell EJ, O'Dorisio TM, Fletcher WS, Howe B.
    Surg Gynecol Obstet; 1988 Dec 01; 167(6):453-62. PubMed ID: 2460958
    [Abstract] [Full Text] [Related]

  • 19. [Pancreatic secreting glucagonoma: inhibitory effect of somatostatin-14 (author's transl)].
    Vinel JP, Pradére B, Voigt JJ, Pradayrol L, Pascal JP.
    Gastroenterol Clin Biol; 1981 Dec 01; 5(12):1155-9. PubMed ID: 6119270
    [No Abstract] [Full Text] [Related]

  • 20. Pancreatic islet cell carcinoma producing gastrin, ACTH, alpha-endorphin, somatostatin and calcitonin.
    Asa SL, Kovacs K, Killinger DW, Marcon N, Platts M.
    Am J Gastroenterol; 1980 Jul 01; 74(1):30-5. PubMed ID: 6107042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.